Putting $15,000 to work in the market is an opportunity to build a solid foundation.
For me, the focus would be on balance. I would want a mix of quality, growth, and resilience rather than relying on a single idea.
That way, my portfolio has the potential to perform across different market conditions while still benefiting from long-term compounding.
Here is how I would think about allocating it today.
Wesfarmers Ltd (ASX: WES)
Wesfarmers would be my starting point. It is one of those businesses that I think can quietly deliver over long periods of time. Its core divisions, particularly Bunnings and Kmart, continue to generate strong earnings supported by well-established market positions.
What I like is the consistency. Even in a mixed economic environment, Wesfarmers has shown it can grow profits and manage costs effectively. That kind of reliability is valuable when building a portfolio.
For me, this would form the defensive core of the investment.
Pro Medicus Ltd (ASX: PME)
Pro Medicus adds a different dimension. This is a high-quality growth company operating in medical imaging software, with a strong global footprint and a history of winning large contracts.
What stands out is the scalability of the business. It generates high margins and strong cash flow, which allows it to grow without the same level of capital intensity as many other healthcare companies.
Its valuation can look elevated at times, but I think that reflects the business' quality and growth potential. And with its shares down heavily over the past 12 months, I believe its valuation is the most attractive it has been in years.
For me, this is the type of ASX share that can drive long-term capital growth.
Aristocrat Leisure Ltd (ASX: ALL)
Aristocrat brings a combination of cash flow and growth. Its gaming business remains highly profitable, while its digital division continues to expand, providing exposure to a growing segment of the market.
What I find appealing is how the company has evolved. It is no longer just a traditional gaming manufacturer. It has built a broader platform that includes digital content and recurring revenue streams.
That diversification can support earnings growth over time.
Foolish takeaway
If I were investing $15,000 in ASX shares today, I would be aiming for a mix of stability and growth.
I think Wesfarmers provides a reliable, high-quality foundation, Pro Medicus offers exposure to a scalable global healthcare business, and Aristocrat adds strong cash flow with an expanding digital growth engine.
Together, I think they could support a balanced portfolio that can perform over the long term.
The post How I'd invest $15,000 in ASX shares right now appeared first on The Motley Fool Australia.
Motley Fool contributor Grace Alvino has positions in Wesfarmers. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Wesfarmers. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2026